Development and Characterization of a High-CBD Cannabis Extract Nanoemulsion for Oral Mucosal Delivery
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311525 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kifah Blal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel. Hauptthemen laut MEDLINE: Cannabis, Mouth Mucosa, Plant Extracts, Cannabidiol. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The cannabidiol (CBD)-rich cannabis extract CAN296 shows anti-inflammatory and anticancer activity relevant to oral lichen planus (OLP), oral graft-versus-host disease (oGVHD), and oral squamous cell carcinoma (OSCC), but its high lipophilicity limits aqueous dispersion. This study developed a stable Tween-based nanoemulsion optimized for oral mucosal delivery. Ethanol-dissolved CAN296 was nanoemulsified using a 1% Tween/Span system. Physical stability was visually assessed; droplet size and morphology were examined by dynamic light scattering (DLS) and transmission electron microscopy (TEM); and wettability was measured by static contact angle (SCA). Additional evaluations included temperature stability (25 °C vs. 4 °C), in vitro release using a dialysis membrane, and scanning electron microscopy (SEM) of membrane-associated droplets. Nanoemulsions with ≥80% Tween 80 incorporated CAN296 up to 800 µg/mL, clear at 400 µg/mL, and uniformly turbid at 800 µg/mL. DLS and TEM confirmed spherical nanoscale droplets, and SCA indicated favorable cohesion and wettability. Stability was maintained for 30 days at 4 °C. Dialysis studies demonstrated strong membrane association with limited diffusion, supported by SEM visualization of membrane-bound droplets. The Tween-dominant (≥80%) nanoemulsion stably incorporated CAN296 up to 800 µg/mL, demonstrated nanoscale uniformity, improved 4 °C stability, and strong membrane retention under static conditions, suggesting potential for localized oral delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112001, Israel.
- Laboratory of Cancer Biology and Natural Drug Discovery, Faculty of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
ORCID-Profile: Kifah Blal, Anna Shapira, David Meiri, Ofra Benny
Zitieren
APA
Blal, K., Maroukian, G., Shapira, A., Procaccia, S., Meiri, D., & Benny, O. (2025). Development and Characterization of a High-CBD Cannabis Extract Nanoemulsion for Oral Mucosal Delivery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311525
Vancouver
Blal K, Maroukian G, Shapira A, Procaccia S, Meiri D, Benny O. Development and Characterization of a High-CBD Cannabis Extract Nanoemulsion for Oral Mucosal Delivery. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311525
BibTeX
@article{Blal2025,
author = {Blal, Kifah and Maroukian, Georgette and Shapira, Anna and Procaccia, Shiri and Meiri, David and Benny, Ofra},
title = {Development and Characterization of a High-CBD Cannabis Extract Nanoemulsion for Oral Mucosal Delivery},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311525}
}
EUVIMED